Wider Todd 4

Accession 0001493152-21-004407

CIK 0000318306other

View on SEC.gov Company Profile

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 4:05 PM ET

Size

36.1 KB

Accession

0001493152-21-004407

Insider Transaction Report

Form 4

Period: 2021-02-17

ABEONA THERAPEUTICS INC.ABEO

Wider Todd

Director

Transactions

Exercise/Conversion
Common Stock
2021-02-17$1.28/sh+50,000$64,000→ 426,625 total
Exercise/Conversion
Stock Option (Right to Buy)
2021-02-17−50,000→ 0 total
Exercise: $1.28From: 2017-05-13Exp: 2026-12-13→ Common Stock (50,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2021-02-17−50,000→ 0 total
Exercise: $1.28From: 2018-09-29Exp: 2028-03-29→ Common Stock (50,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2021-02-17−20,173→ 1,345 total
Exercise: $1.28From: 2020-11-20Exp: 2030-05-20→ Common Stock (20,173 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2021-02-18−1,345→ 0 total
Exercise: $1.28From: 2020-11-20Exp: 2030-05-20→ Common Stock (1,345 underlying)
Exercise/Conversion
Common Stock
2021-02-17$1.28/sh+50,000$64,000→ 476,625 total
Exercise/Conversion
Common Stock
2021-02-17$1.28/sh+100,000$128,000→ 376,625 total
Exercise/Conversion
Common Stock
2021-02-17$1.28/sh+30,000$38,400→ 506,625 total
Exercise/Conversion
Common Stock
2021-02-17$1.28/sh+50,000$64,000→ 566,625 total
Exercise/Conversion
Common Stock
2021-02-17$1.28/sh+19,827$25,379→ 576,452 total
Exercise/Conversion
Common Stock
2021-02-17$1.28/sh+20,173$25,821→ 596,625 total
Sale
Common Stock
2021-02-17$2.34/sh−320,000$749,792→ 276,625 total
Exercise/Conversion
Common Stock
2021-02-18$1.28/sh+1,345$1,722→ 277,970 total
Sale
Common Stock
2021-02-18$2.43/sh−1,345$3,273→ 276,625 total
Exercise/Conversion
Stock Option (Right to Buy)
2021-02-17−100,000→ 0 total
Exercise: $1.28From: 2015-11-11Exp: 2025-05-11→ Common Stock (100,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2021-02-17−50,000→ 0 total
Exercise: $1.28From: 2016-08-11Exp: 2026-02-11→ Common Stock (50,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2021-02-17−30,000→ 0 total
Exercise: $1.28From: 2018-05-14Exp: 2027-12-14→ Common Stock (30,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2021-02-17−19,827→ 0 total
Exercise: $1.28From: 2019-11-21Exp: 2029-05-21→ Common Stock (19,827 underlying)

Footnotes (2)

[F1]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.30 to $2.475, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.
[F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.43 to $2.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.

Documents

1 file

4
ownership.xmlPrimary

Issuer

ABEONA THERAPEUTICS INC.

CIK 0000318306

→

Entity typeother

Related Parties

filerCIK 0001642715

Filing Metadata

Form type: 4
Filed: Feb 18, 7:00 PM ET
Accepted: Feb 19, 4:05 PM ET
Size: 36.1 KB

View on SEC.gov